# US 2024/0366699 A1 · Yeast for the treatment of inflammation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0366699 A1
- Document ID: US20240366699A1
- Status: Published application
- Kind: A1
- Application number: 18/573,574
- Filed: 2022-06-29
- Published: 2024-11-07
- Earliest claimed: 2021-06-29
- Assignees: Milmed Unico AB
- Applicants: Milmed Unico AB
- Inventors: Trevor ARCHER; Rita BUSINARO; Tomas LENZ
- Web page: https://patentgrep.com/patent/US20240366699A1

## CPC

- A61K 36/064: Saccharomycetales, e.g. baker's yeast
- A61K 41/00: Medicinal preparations obtained by treating materials with wave energy or particle radiation {; Therapies using these preparations}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C12N 1/185: Saccharomyces isolates
- C12N 13/00: Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
- C12R 2001/86: Saccharomyces carlsbergensis {; Saccharomyces pastorianus}
- C12R 2001/865: Saccharomyces cerevisiae
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

A yeast cell for use in the treatment and/or alleviation of inflammation and/or symptoms caused by inflammation, wherein the yeast cell has been treated with electromagnetic waves in the range of 1 GHz to 300 GHz, or said yeast cell has been grown from a yeast cell treated with electromagnetic waves in the range of 1 GHz to 300 GHz, and composition comprising such a yeast cell.

## Claims

### Claim 1

A yeast cell for use in the treatment and/or alleviation of inflammation and/or symptoms caused by inflammation, wherein the yeast cell has been treated with electromagnetic waves in the range of 1 GHz to 300 GHz, or said yeast cell has been grown from a yeast cell treated with electromagnetic waves in the range of 1 GHz to 300 GHz.

### Claim 2 (depends on 1)

The yeast cell for use according to claim 1, wherein the inflammation is selected from the group consisting of inflammatory bowel disease, irritable bowel syndrome; an autoimmune disease, and an inflammation caused by a microorganism and/or wherein the symptom caused by inflammation is chosen from the group consisting of heat, pain, redness, swelling, loss of function and combinations thereof.

### Claim 3 (depends on 1)

The yeast cell for use according to claim 1, wherein the inflammation is inflammatory bowel disease, such as Crohn's disease or ulcerative colitis; or irritable bowel syndrome.

### Claim 4 (depends on 1)

The yeast cell for use according to claim 1, wherein said electromagnetic waves are in the range from about 1 GHz to about 200 GHz, such as 10 to 100 GHz, such as 30 to 70 GHz, such as 40 to 65 GHz.

### Claim 5

The yeast cell for use according to 4, wherein said electromagnetic waves are chosen from group consisting of: 30 GHz, 31 GHz, 32 GHz, 33 GHz, 34 GHz, 35 GHz, 36 GHz, 37 GHz, 37.5 GHz, 38 GHz, 39 GHz, 40 GHz, 41 GHz, 42 GHz, 43 GHz, 44 GHz, 45 GHz, 46 GHz, 47 GHz, 48 GHz, 49 GHz, 50 GHz, 51 GHz, 52 GHz, 53 GHz, 54 GHz, 55 GHz, 56 GHz, 57 GHz, 58 GHz, 59 GHz, 60 GHz, 61 GHz, 62 GHz, 63 GHz, 64 GHz, 65 GHz, 66 GHz, 67 GHz, 68 GHz, 69 GHz, 70 GHz, 71 GHz, 72 GHz, 73 GHz, 74 GHz, 75 GHz, 76 GHz, 77 GHz, 78 GHz, 79 GHz, 80 GHz, 81 GHz, 82 GHz, 83 GHz, 84 GHz, 85 GHz, 86 GHz, 87 GHz, 88 GHz, 89 GHz and 90 GHz.

### Claim 6 (depends on 1)

The yeast cell for use according to claim 1, wherein said electromagnetic waves have a power density below 1 mW/cm2; preferably said electromagnetic waves have a power density of between 0.004 mW/cm2 and 0.2 mW/cm2.

### Claim 7 (depends on 1)

The yeast cell for use according to claim 1, wherein said electromagnetic waves are modulated in a frequency within the range of 0.01% to about 0.5% of the average frequency.

### Claim 8 (depends on 1)

The yeast cell for use according to claim 1, wherein said yeast cell has been treated with electromagnetic waves for a time period of from 10 minutes to 240 minutes, such as from 20 minutes to 130 minutes, such as from 20 minutes to 120 minutes, such as from 30 minutes to 90 minutes, such as from 35 minutes to 85 minutes, such as 45 minutes to 80 minutes, such as 40 minutes, such as 50 minutes, such as 60 minutes, such as 70 minutes, such as 80 minutes.

### Claim 9 (depends on 1)

The yeast cell for use according to claim 1, wherein said yeast cell is of the genus Saccharomyces, such as a yeast cell being selected from the group consisting of Saccharomyces carlsbergensis or Saccharomyces cerevisiae.

### Claim 10

A composition for use in the treatment and/or alleviation of inflammation and/or symptoms caused by inflammation, comprising at least one yeast cell according to any one of the previous claims and an excipient and/or a carrier.

### Claim 11 (depends on 10)

The composition for use according to claim 10, wherein the composition further comprises at least one vitamin and/or at least one mineral.

### Claim 12 (depends on 10)

The composition for use according to claim 10, wherein the composition is for oral intake.

### Claim 13 (depends on 10)

The composition for use according to claim 10, wherein the composition is a liquid composition.

### Claim 14 (depends on 13)

The composition for use according to claim 13, wherein the composition comprises the yeast cell in an amount of from 10×106 CFUs/ml to 50×106 CFUs/ml, preferably from 20×106 CFUs/ml to 40×106 CFUs/ml, such as 30×106 CFUs/ml.

### Claim 15 (depends on 10)

The composition for use according to claim 10, wherein the composition is a powder composition.
